Re: Cramer Presents Stem Cell Therapeutics Corp.'s Final Phase IIa BETAS Trial
posted on
Jun 29, 2024 11:31AM
Stem Cell is a public biotechnology company focused on the development and commercialization of drug-based therapies to treat central nervous system diseases.